Johnson & Johnson vs. Savara Inc.
Johnson & Johnson and Savara Inc. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| JNJ | SVRA | |
|---|---|---|
| Market Cap | $652.31 billion | $1.04 billion |
| Revenue (TTM) | $97.93 billion | — |
| Net Income (TTM) | $21.04 billion | $-139,309,000 |
JNJ leads on 3 of 3 size & scale factors.
Valuation
| JNJ | SVRA | |
|---|---|---|
| P/E Ratio | 31.46 | — |
| Price / Book | 7.68 | -1950.72 |
| Price / Sales | 6.66 | — |
SVRA leads on 1 of 1 valuation factors.
Profitability
| JNJ | SVRA | |
|---|---|---|
| Net Margin | 21.48% | — |
| Return on Equity | 24.76% | 26087.83% |
SVRA leads on 1 of 1 profitability factors.
Dividend
| JNJ | SVRA | |
|---|---|---|
| Dividend Yield | 1.98% | — |
| Payout Ratio | 62.18 | — |
JNJ and SVRA split the dividend factors evenly.
Risk & Sentiment
| JNJ | SVRA | |
|---|---|---|
| Short Interest | 0.67% | 0.16% |
SVRA leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, SVRA overview, SVRA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.